|22.63||+2.96 / +15.05%|
As of 4:00pm ET
|22.84||+0.21 / +0.93%|
The 5 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 32.00, with a high estimate of 45.00 and a low estimate of 30.00. The median estimate represents a +41.41% increase from the last price of 22.63.
The current consensus among 5 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.